期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

21-三体综合征产前筛查 被引量：2

下载PDF
导出
摘要 在以智力低下为主要临床表现的常染色体疾病中,21-三体综合征是最为常见的一种。由于该病目前尚无有效的治疗手段,因而产前早期诊断、终止妊娠是明智之举。近年来许多学者致力于孕早、中期母体血清标记物的筛查及胎儿的超声波检查,以期达到优生的目的。
作者 敬琴珍
机构地区 四川省华蓥市华蓥山广能集团总医院内二科
出处 《牡丹江医学院学报》 2006年第6期51-53,共3页 Journal of Mudanjiang Medical University
关键词 21-三体综合征 染色体 产前筛查
分类号 R714.5 [医药卫生—妇产科学]
  • 相关文献

参考文献15

  • 1唐格非.临床生物化学和生物化学检验[M].第二版.北京:人民卫生出版社,1999:357.
  • 2鲍培忠.多种血清标记物在产前筛查中作用的综合评价[J].国外医学（计划生育分册）,1999,18(2):74-78. 被引量：56
  • 3W ald NJ,Kennard A,W att Hc,et al.Value of maternal serum unconjugatedoestriol measurement in prenatal screening for Down's syndrome[J].Prenat Diagn,1994,14(8):699.
  • 4李华锋,李征艳,张献陆.妊娠相关蛋白A用于唐氏综合征产前筛查的研究[J].华北煤炭医学院学报,2004,6(5):569-570. 被引量：1
  • 5Goodbum SF,Yates JR,Baggatt PR,et al.Second-trimester maternal serum screening using alpha -fetoprotein,human chofionic go-nadotrophin,and uneonjugated oestriol:experience of a regional programme.Prenat Diagn,1994,14 (5):391 ～ 402.
  • 6谢有明.人类21-三体的发生[J].国外医学：遗传学分册,1995,8(4):194-194.
  • 7Merkatz IR,Nitowsky HM,Macri JN,et al.An associatioil between low maternal serum alpha -fetoprotein and fetal chromosomal abnormalities.Am J Obstet Gynecol,1984,148 (7):886-894.
  • 8Haddow J E.Palomaki G E,KnightG J et al.Screening ofmaternal serum forfetal Down' S syndrome in the first trimester.N Ensl J Med",1998,338 (5):955.
  • 9Aitken DA,Wallace EM,Crossley JA,et al.Dimetric inbibin A as a marker for Down's syndromein early pregnancy.N Engl JMed,1996,334(19):1231-1236.
  • 10付广红,罗坚真,刘艳秋.21-三体综合征产前筛查与产前诊断[J].江西医药,2005,40(11):768-771. 被引量：7

二级参考文献47

  • 1谢佐俊,刘雯,李华,王世雄,胡琴,乔明敏,李锦燕,左伋.与Down′s综合征发生相关的环境因子的流行病学分析[J].中国优生与遗传杂志,2004,12(6):41-43. 被引量：14
  • 2[1]Korenberg JR, et al. Down Syndrome phenotypes:the consequences of chromosomal imbalance[ J ]. Proc Natl Acad Sci, 1994,91: 4997- 5001.
  • 3Wald NJ, Kennard A, Hackshaw A, et al .Antenatal screening for Down's syndrome [J]. J Med Screen, 1997,4: 181-246.
  • 4Merkatz IR, Nitowaky HM, Macrl JN, et al. An association between low maternal serum alpha- fetoprotein and fetal chromosomal abnormalities [ J ]. Am J Obstet Gynecol,1984, 148: 886.
  • 5Wald NJ, Watt HC, Hackshaw AK. Integrated screening for down's syndrome [J]. Br J O bstet Gynaecol, 1988,95 : 334.
  • 6Jobanputra V, Roy KK, Kucheria K. Prenatal detection of aneuploidies using fluorescence in situ hybridization: a preliminary experience in an Indian set up. J Biosci,2002,27(2): 155-163
  • 7Miny P, Tercanli S, Holzgreve W. Developments in laboratory techniques for prenatal diagnosis. Curr Opin Obstet Gynecol, 2002,14(2) : 161-168
  • 8Speel EJ, Ramaekers FC, Hopman AH. PCR-based detection of nucleic acids in chromosomes, cells, and tissues: technical considerations on PRINS and in situ PCR and comparison with in situ hybridization. Methods Mol Biol, 2003,226 ( 5 ): 405-424
  • 9Raty R, Anttila L, Virtanen A. Maternal midtrimester free betaHCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis. Prenat Diagn, 2003,23 ( 13 )
  • 10Palomaki GE, Knight GJ, Roberson MM. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in secondtrimester maternal urine as a marker for Down syndrome: preliminary results of an observational study on fresh samples. Clin Chem,2

共引文献78

同被引文献37

  • 1Boorrnans EM, Birnie E, Wildschut HI, et al. Multiplex ligation- dependent probe amplification vel~us karyotyping in prenatal diag- nosis: the M. A. K. E. study[ J ]. BMC Pregnancy Childbirth, 2008, 8:18.
  • 2Price JO, Elias S, Wachtel SS, et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytornetry [J]. ArnJ Obstet Gynecol,1991,165(6 Pt 1 ) :1731-1737.
  • 3Zheng YL, Zhen DK, Farina A, et al. Fetal cell identifiers : results of microscope slide-based immunocytochemical studies as a function of gestational age and abnormality [ J ]. Am J Obstet Gynecol, 1999,180 ( 5 ) : 1234 -1239.
  • 4Wachtel SS, Sammons, Manley, et al. Fetal ceils in maternal blood: recovery by charge flow separation[J]. Hum Genet, 1996, 98 (2) : 162-166.
  • 5Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in materna/ plasma and serum [J]. Lancet, 1997, 350 (9076) : 485-487.
  • 6Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma[J]. Clin Chern, 2004,50( 1 ) :88-92.
  • 7Koide K, Sekizawa A, Iwasaki M,et al. Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women[J ]. Prenat Di- agn, 2005,25 (7) :604-607.
  • 8Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis [J]. Am J Hum Genet, 1998,62(4) :768-775.
  • 9Guibert J, Benachi A, Grebille AG, et al. Kinetics ofSRY gene appear-ance in maternal serum: detection by real time PCRin early pregnancy after assisted reproductive technique [ J ]. Hum Re- prod, 2003,18 (8) : 1733-1736.
  • 10Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma[J]. AmJ Hum Genet, 1999, 64( 1 ) : 218- 224.

引证文献2

二级引证文献3

牡丹江医学院学报
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部